GlassScriptPhysician profile
Yasser Refaat Farid
NPI 1720309842
$3,907.73
in general payments reported to CMS, 2019-2025
9 companies · $37.18 in 2025
The $37.18 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2021: $36.18 · 2022: $1,281 · 2023: $2,489 · 2024: $49.48 · 2025: $37.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,009 · Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,009.45 |
| Food and Beverage | $566.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,640.67 | 2022-2023 | Journey II, Real Intelligence, Redapt |
| Heraeus Medical, LLC. | $100.09 | 2021-2022 | |
| Organogenesis INC. | $36.16 | 2021-2022 | |
| Orthofix Medical, INC. | $29.15 | 2022 | |
| Acera Surgical, INC. | $24.99 | 2024 | Restrata Wound Matrix |
| Sanara Medtech INC. | $24.49 | 2024 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $19.43 | 2025 | |
| Stryker Corporation | $17.75 | 2025 | Aequalis Flex Revive |
| Zimmer Biomet Holdings, INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasser Farid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.